Concordia Healthcare (CXRX) Misses Q2 EPS by 4c; CFO de Saldanha to Resign; Dividend Suspended
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Concordia (CXRX) Reports Cross Currency Swap Agreement
August 15, 2016 1:17 PM EDTConcordia International Corp. (NASDAQ: CXRX) together with its subsidiaries ("Concordia") - an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, today announced that it has entered into a cross currency swap agreement (the "Swap Agreement").
As previously disclosed, Concordia was actively evaluating... More
GMP Securities Downgrades Concordia Healthcare (CXRX) to Hold
August 15, 2016 8:23 AM EDTGMP Securities downgraded Concordia Healthcare (NASDAQ: CXRX) from Buy to Hold.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreCIBC Downgrades Concordia Healthcare (CXRX) to Sector Underperform
August 15, 2016 8:18 AM EDTCIBC downgraded Concordia Healthcare (NASDAQ: CXRX) from Sector Perform to Sector Underperform with a price target of $7.80.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreRBC Capital Cuts PT on Concordia Int'l (CXRX) to $27 Following Q2 REsults
August 15, 2016 6:27 AM EDTRBC Capital lowers its price target on Outperform-rated Concordia International (Nasdaq: CXRX) from $33 down to $27 following Q2 results last week.
The firm commented, Although we had recently revised our forecasts to reflect FX impact post-Brexit and weakness in the U.S. legacy... More
RBC Affirms Concordia (CXRX) at 'Outperform' as Q2 Profit Meets Lowered Expectations
August 12, 2016 9:24 AM EDTRBC Capital is out with initial commentary on Concordia International (Nasdaq: CXRX) following Q2 results and other matters announced earlier. The firm rates CXRX at Outperform wth a price target of $33.
Analyst Douglas Miehm commented, CXRX's Q2 results, which faced lower expectations from... More
